CND Special Event

Under the theme #ShareFactsonDrugs #SaveLives, the Commission on Narcotic Drugs Special Event commemorated the International Day against Drug Abuse and Illicit Trafficking and launched the 2021 World Drug Report on Friday, 25 June 2021, from 1.30 p.m. to 3.30 p.m. Vienna time (CEST), Board-Room D, Vienna International Center and online.

Programme

Welcoming remarks and moderation by H.E. Ms. Dominika Krois, Permanent Representative of Poland to the United Nations (Vienna) and Chair of the Commission on Narcotic Drugs
Opening remarks by Ms. Ghada Waly, Executive Director of the United Nations Office on Drugs and Crime
Presentation of main findings of the 2021 World Drug Report Ms. Angela Me, Chief of the UNODC Research and Trend Analysis Branch
Remarks by Mr. Wang Pengchao and Ms. Sarah Jul-Rasmussen, Youth Representatives
Panel
H.E. Mr. Miguel Camilo Ruiz Blanco, Permanent Representative of Colombia to the United Nations (Vienna)
H.E. Mr. Suleiman Dauda Umar, Permanent Representative of Nigeria to the United Nations (Vienna)
Ms. Begaiym Nurlan, Permanent Mission of Kyrgyzstan to the United Nations (Vienna)
Ms. Jagjit Pavadia, President of the International Narcotics Control Board
Mr. Jamie Bridge, Chair of the Vienna NGO Committee on Drugs
Questions and Answers

Statements

Statements are published at the request of delegations.

Ecuador

United States of America

Australasian Palliative Link International statement, video

Proyecto Hombre statementvideo 

Youth RISE statement,  video 

Vienna NGO Committee on Narcotic Drugs statement, video

Webcast

The webcast of the special event was available on this page.

COVID-19 Guidelines for in-person participants

Due to the COVID-19 pandemic, the special event was held in a hybrid format, combining a limited in-person component with an online participation for participants worldwide.

COVID-19 guidance for meetings participants at the Special commemorative event

World Drug Report 2021

Presented in five separate booklets, the World Drug Report 2021 provides a wealth of information and analysis to support the international community in implementing international drug policy commitments. 
Booklet 1 summarizes the four subsequent booklets by reviewing their key findings and highlighting their policy implications. Booklet 2 offers a projection of the impact of population growth on drug use by 2030; it continues with a global overview of the latest trends and estimates on the supply of and demand for drugs, including , its health impact, and addresses the trafficking of substances for drug markets on the Internet. Booklet 3 provides an analysis of the global markets for cannabis and opioids, both in terms of supply and use; it includes an overview of the latest developments in countries with measures regulating the non-medical use of cannabis. It also discusses the overlaps between the various opioids, and access to pharmaceutical opioids. Booklet 4 provides the latest trends and estimates on markets for stimulants - cocaine, methamphetamine, amphetamine and “ecstasy”, at the global level and in the most affected subregions. Booklet 5 concludes by providing an early assessment of the impact of the COVID-19 pandemic on drug markets by looking at how it has affected drug supply and demand dynamics, including in terms of health consequences and how drug service provision has adapted to the new situation in many countries.